XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Compensation, Employment Agreements and Other Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2020
Compensation Related Costs [Abstract]  
Schedule of restricted stock units activity
The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2020, 2019 and 2018:
 
 For the Year Ended December 31, 2020
RSUs With
Service
Condition		Weighted
Average
Grant Date
Fair Value		RSUs With
Market and
Service
Conditions		Weighted
Average
Grant Date
Fair Value		Total
RSUs		Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:1,379,681 $7.62 1,301,250 $6.78 2,680,931 $7.21 
Granted (1)
939,046 4.88 763,174 5.50 1,702,220 5.16 
Settled(379,272)7.75 (441,250)6.48 (820,522)7.07 
Cancelled/forfeited(110,000)7.59 — — (110,000)7.59 
Outstanding at end of year1,829,455 $6.19 1,623,174 $6.26 3,452,629 $6.22 
RSUs vested but not settled at end of year
1,160,416 $5.37 409,000 $6.91 1,569,416 $5.77 
RSUs unvested at end of year669,039 $7.61 1,214,174 $6.04 1,883,213 $6.60 
 
 For the Year Ended December 31, 2019
 RSUs With
Service
Condition		Weighted
Average
Grant Date
Fair Value		RSUs With
Market and
Service
Conditions		Weighted
Average
Grant Date
Fair Value		Total
RSUs		Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:1,206,446 $7.57 1,151,250 $6.21 2,357,696 $6.90 
Granted (2)
461,525 7.35 451,000 6.97 912,525 7.16 
Settled(269,290)6.93 (290,000)4.81 (559,290)5.83 
Cancelled/forfeited(19,000)7.72 (11,000)6.71 (30,000)7.35 
Outstanding at end of year1,379,681 $7.62 1,301,250 $6.78 2,680,931 $7.21 
RSUs vested but not settled at end of year
809,681 $7.70 441,250 $6.48 1,250,931 $7.27 
RSUs unvested at end of year570,000 $7.50 860,000 $6.94 1,430,000 $7.16 
 
 For the Year Ended December 31, 2018
 RSUs With
Service
Condition		Weighted
Average
Grant Date
Fair Value		RSUs With
Market and
Service
Conditions		Weighted
Average
Grant Date
Fair Value		Total
RSUs		Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:1,025,028 $7.67 1,021,250 $5.80 2,046,278 $6.73 
Granted (3)
428,802 7.65 415,000 6.91 843,802 7.29 
Settled(237,384)8.17 (275,000)5.73 (512,384)6.86 
Cancelled/forfeited(10,000)7.23 (10,000)5.64 (20,000)6.44 
Outstanding at end of year1,206,446 $7.57 1,151,250 $6.21 2,357,696 $6.90 
RSUs vested but not settled at end of year
708,946 $7.47 290,000 $4.81 998,946 $6.70 
RSUs unvested at end of year497,500 $7.71 861,250 $6.69 1,358,750 $7.06 

(1)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 1,204,713 of these awards granted in 2020, the Company applied:  (i) a weighted average volatility estimate of approximately 14%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 1.36% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards.  The weighted average grant date fair value for the remaining 452,585 and 44,922 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $2.32 and $2.56, respectively. There are no post vesting conditions on these awards.
(2)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 752,500 of these awards granted in 2019, the Company applied: (i) a weighted average volatility estimate of approximately 15%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 2.47% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards. The weighted average grant date fair value for the remaining 160,025 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.28. There are no post vesting conditions on these awards.
(3)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 692,500 of these awards granted in 2018, the Company applied: (i) a weighted average volatility estimate of approximately 17%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 2.36% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards. The weighted average grant date fair value for the remaining 151,302 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.70. There are no post vesting conditions on these awards.
Schedule of restricted stock activity
The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2020, 2019 and 2018:
 
 For the Year Ended December 31,
 202020192018
Shares of
Restricted
Stock
Weighted
Average
Grant Date
Fair Value (1)
Shares of
Restricted
Stock
Weighted
Average
Grant Date
Fair Value (1)
Shares of
Restricted
Stock
Weighted
Average
Grant Date
Fair Value (1)
Outstanding at beginning of year:— $— — $— — $— 
Granted
79,545 1.65 412,185 7.83 450,193 6.74 
Vested (2)
(79,545)1.65 (412,185)7.83 (450,193)6.74 
Cancelled/forfeited
— — — — — — 
Outstanding at end of year— $— — $— — $— 

(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.
(2) All restrictions associated with restricted stock are removed on vesting.
Schedule of expenses related to equity-based compensation
The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2020, 2019 and 2018:
 
 For the Year Ended December 31,
(In Thousands)202020192018
RSUs$6,592 $6,012 $4,974 
Restricted shares of common stock131 3,227 3,033 
Total$6,723 $9,239 $8,007 
Schedule of expenses related to deferred compensation plans The following table presents the Company’s expenses related to its Deferred Plans for the years ended December 31, 2020, 2019 and 2018:
 
 For the Year Ended December 31,
(In Thousands)202020192018
Non-employee directors$(911)$663 $(165)
Total$(911)$663 $(165)
Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2020 and 2019 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2020 and 2019:
 
 December 31, 2020December 31, 2019
(In Thousands)
Undistributed
Income
Deferred (1)
Liability Under
Deferred Plans
Undistributed
Income
Deferred (1)
Liability Under
Deferred Plans
Non-employee directors$2,197 $1,809 $2,349 $3,071 
Total$2,197 $1,809 $2,349 $3,071 

(1)Represents the cumulative amounts that were deferred by participants through December 31, 2020 and 2019, which had not been distributed through such respective date.